LPL Financial
AXSM icon

LPL Financial’s Axsome Therapeutics AXSM Stock Holding History

LPL Financial’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.96M Buy
47,111
+16,703
+55% +$2.89M ﹤0.01% 2194
2025
Q4 		$5.55M Buy
30,408
+3,951
+15% +$552K ﹤0.01% 2441
2025
Q3 		$3.21M Buy
26,457
+2,211
+9% +$249K ﹤0.01% 2877
2025
Q2 		$2.53M Buy
24,246
+1,112
+5% +$118K ﹤0.01% 2904
2025
Q1 		$2.7M Sell
23,134
-1,075
-4% -$122K ﹤0.01% 2682
2024
Q4 		$2.05M Buy
24,209
+7,837
+48% +$721K ﹤0.01% 2843
2024
Q3 		$1.47M Buy
16,372
+1,491
+10% +$130K ﹤0.01% 3019
2024
Q2 		$1.2M Sell
14,881
-1,154
-7% -$85.4K ﹤0.01% 3086
2024
Q1 		$1.28M Buy
16,035
+5,640
+54% +$473K ﹤0.01% 2962
2023
Q4 		$827K Buy
10,395
+1,896
+22% +$127K ﹤0.01% 3212
2023
Q3 		$594K Sell
8,499
-99
-1% -$7.4K ﹤0.01% 3335
2023
Q2 		$618K Sell
8,598
-50
-0.6% -$3.69K ﹤0.01% 3250
2023
Q1 		$533K Buy
8,648
+1,014
+13% +$66.6K ﹤0.01% 3268
2022
Q4 		$589K Sell
7,634
-1,711
-18% -$102K ﹤0.01% 3097
2022
Q3 		$417K Buy
9,345
+487
+5% +$24.3K ﹤0.01% 3314
2022
Q2 		$339K Sell
8,858
-1,453
-14% -$46K ﹤0.01% 3531
2022
Q1 		$427K Sell
10,311
-1,984
-16% -$61.5K ﹤0.01% 3318
2021
Q4 		$465K Buy
12,295
+1,079
+10% +$39.7K ﹤0.01% 3337
2021
Q3 		$370K Buy
11,216
+7,353
+190% +$287K ﹤0.01% 3479
2021
Q2 		$261K Buy
+3,863
New +$232K ﹤0.01% 3695

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LPL Financial's AXSM Position: Q1 2026 in Review

LPL Financial increased its Axsome Therapeutics (AXSM) stake by 55% in Q1 2026, buying an estimated $2.89M and bringing the position to 47,111 shares worth $7.96M. The position accounts for ﹤0.01% of the portfolio, ranked #2194.

LPL Financial first reported a position in AXSM in Q2 2021 and has held it in 20 quarters since. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • LPL Financial held 47,111 shares of Axsome Therapeutics worth $7.96M as of Q1 2026.
  • LPL Financial bought 16,703 Axsome Therapeutics shares in Q1 2026, an estimated $2.89M.
  • Axsome Therapeutics made up ﹤0.01% of LPL Financial's portfolio in Q1 2026, its #2194 holding.
  • LPL Financial first reported a position in Axsome Therapeutics in Q2 2021 and has held it in 20 quarters since.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.